UNSPSC 51263104: Alprenolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 877K5MQ27W, chemically known as 2-propanol, 1-(o-allylphenoxy)-3-(isopropylamino)- but generally known as alprenolol, which bears US NIH Compound Identifier 2119. Alprenolol most often comes in glucuronide and hydrochloride forms. European Medicines Agency schedules Alprenolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05371MIG.

UNSPSC 51263104 Alprenolol is a Commodity code, but the recent state and local procurement activity tagged under it does not reflect pharmaceutical alprenolol sales. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, a public-health and harm-reduction solicitation bearing no relationship to the code's nominal pharmaceutical scope. The mismatch suggests either a tagging error in the county's e-procurement system or a code misapplication by the procurement office.

The single recent opportunity on record shows no other issuing bodies, no geographic spread across multiple jurisdictions, and no representative activity that would support a meaningful business development strategy under this code. State and local procurement activity under UNSPSC 51263104 is not evident in current opportunities.